Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Arcoral Pharma AS
AS
Active
Org 996673898
Reistadlia 32, 3425
Reistad
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Arcoral Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−81
−90
−18
−12
−18
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−81
−90
−18
−12
−18
Net financials
14
0
−0
−0
−0
Profit before tax
−67
−90
−18
−12
−18
Tax
−15
−20
−4
−3
−4
Net profit
−52
−70
−14
−9
−14
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
243
310
406
437
464
Equity
230
282
352
366
375
Long-term debt
0
27
46
58
73
Short-term debt
2
2
8
13
16
Total debt
14
28
54
71
89
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
94,4 %
This company
38,2 %
Market median
This company
Market median
147% above market
2021
2025
Return on equity
−22,6 %
This company
18,4 %
Market median
This company
Market median
223% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,06×
This company
0,62×
Market median
This company
Market median
90% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Arcoral Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
